C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
11/2011
11/10/2011	WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	WO2011082245A3 Metalloenzyme inhibitor compounds
11/10/2011	US20110275828 Process for the preparation of irbesartan
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/09/2011	EP2384323A1 Intravascular contrast agents
11/09/2011	EP1658263B9 Novel aminobenzophenone compounds
11/09/2011	CN102233140A Chemical composition for radiation and chemotherapy
11/09/2011	CN101343251B Thrombopoietin mimetics
11/08/2011	US8053582 Process for making tetrazole based cross-linked polymers
11/03/2011	WO2011104725A3 Intermediates for the preparation of hmg-coa reductase inhibitors and processes for the preparation thereof
11/03/2011	US20110268663 Intravascular contrast agents
11/02/2011	EP2382189A1 Toluidine sulfonamides and their use
11/02/2011	EP1535914B1 Processes for producing epoxytriazole derivative and intermediate therefor
11/01/2011	US8048905 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
11/01/2011	US8048903 5-iodotetrazoles
10/2011
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011132480A1 Tetrazolium compound for detecting microorganisms, reagent for detecting microorganisms and method for detecting microorganisms
10/27/2011	WO2011131613A1 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
10/27/2011	DE102011014082A1 Preparing substituted tetrazole compounds, useful e.g. as important components of various drugs e.g. antibiotics or antiallergic agent, comprises reacting cyano compounds with azide compounds in a reaction medium containing ionic liquid(s)
10/27/2011	CA2796710A1 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
10/26/2011	EP2379531A1 Processes for the manufacture of 3-{4-methyl-5- [ (ir) -1- (2- (3-methylphenyl) -2h-tetrazol-5-yl) -ethoxy]-4h- [1,2, 4]triazol-3-yl} -pyridine, 4-methyl-3-methylthio-5- (3- pyridyl)-l,2,4-triazole, and (ir) -1- [2- (3-methylphenyl) -2h- tetrazol-5-yl]ethanol
10/25/2011	US8044081 Aminoderivative of biotin and their conjugates with macrocyclic chelating agents
10/20/2011	WO2011046380A3 Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110256067 Contrast agents endowed with high relaxivity
10/19/2011	EP2377855A1 A valsartanamide dinitrate derivative for the treatment of vascular and metabolic diseases
10/19/2011	EP2377840A2 5,5'-azotetrazolate explosive
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN1993357B Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
10/18/2011	US8039636 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
10/18/2011	US8039496 Therapeutic compounds
10/13/2011	WO2011124655A1 Improved process for preparing valsartan
10/13/2011	US20110251393 Helicene derivative, axially asymmetric amino acid, amine or aminoalcohol derivative, perylene derivative or salt thereof, and methods for producing same
10/13/2011	US20110251248 Glucagon receptor antagonist compounds
10/12/2011	EP2374788A1 Indanyl compounds
10/12/2011	EP2373630A1 Nitrooxy derivatives as angiotensin ii receptor antagonists
10/12/2011	CN102216249A Naphthylacetic acids
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	US8034800 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
10/06/2011	WO2011121592A1 Process for irbesartan substantially free of dimmer impurity
10/06/2011	WO2011121505A1 Cytokine inhibitors
10/06/2011	CA2794676A1 Cytokine inhibitors
10/05/2011	EP2369924A1 Nitrooxy cycloalkane derivatives
10/04/2011	CA2381123C Actinium-225 complexes and conjugates for radioimmunotherapy
09/2011
09/29/2011	US20110237633 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/29/2011	US20110237628 Cyclopentyl- and cycloheptylpyrazoles
09/29/2011	DE102010013833A1 Producing gadolinium complex of N-(hydroxymethyl-dihydroxypropyl)-tri scarboxymethyl-tetraazacyclododecane useful as magnetic resonance imaging contrast agent, comprises e.g. reacting cyclic compound with dimethylformamide dimethylacetal
09/28/2011	EP2367803A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
09/22/2011	US20110230662 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging
09/22/2011	US20110230532 Nitrooxy cycloalkane derivatives
09/22/2011	US20110230428 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
09/22/2011	US20110229409 Linkable lewis x analogs
09/21/2011	EP2365966A1 Method of removing the triphenylmethane protection group
09/21/2011	CN101696142B Preparation method of HMX particle with regular morphology
09/21/2011	CN101362730B Method for preparing losartan side chain compound
09/21/2011	CN101343250B Thrombopoietin mimetics
09/20/2011	US8022207 Compound having affinity to amyloid
09/20/2011	CA2505033C Non-nucleoside reverse transcriptase inhibitors
09/20/2011	CA2471943C .beta.-amyloid protein production-secretion inhibitors
09/20/2011	CA2439415C Cathepsin cysteine protease inhibitors
09/20/2011	CA2115828C Calcium receptor active molecules
09/15/2011	WO2011110651A1 Process for the preparation of 5-substituted 1-alkyltetrazoles
09/14/2011	EP1644344B1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cyclene and functionalised cyclenes
09/14/2011	CN102186845A S1p receptors modulators and their use thereof
09/13/2011	US8017768 Catalitic synthesis of caged polynitramine compounds
09/13/2011	CA2454125C Novel materials for selective trapping of carbon monoxide
09/09/2011	WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor
09/01/2011	WO2011104725A2 Hmg-coa reductase inhibitors and process for the preparation thereof
09/01/2011	DE102009057274B4 Gadobutrolherstellung mittels Trioxobicyclo-octan Gadobutrolherstellung by Trioxobicyclo-octane
09/01/2011	DE102009053252B3 Making gadobutrol, to diagnose stroke, comprises e.g. reacting N-(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-tetraaza-cyclododecane lithium chloride or bromide complex with haloacetic acid and lithium hydroxide or N-methyl imidazole
08/2011
08/31/2011	CN102171190A Insecticidal benzenedicarboxamide derivative
08/30/2011	CA2645294C Dibenzyl amine compounds and derivatives
08/25/2011	WO2011102626A2 Polyazamacrocyclic compound, and a production method and a biomedical use therefor
08/25/2011	WO2011101445A1 High-affinity multivalent chelator compounds (mchs) and their use for the structural and functional analysis of target molecules
08/25/2011	US20110206653 Tetrazole compounds for reducing uric acid
08/24/2011	CN102164901A Process for the preparation of calcobutrol
08/23/2011	US8003801 Chemical synthesis of a highly potent epothilone
08/23/2011	US8003680 Therapeutic compounds
08/18/2011	US20110201610 Aryl sulfonamides
08/18/2011	DE102010008417A1 Hochaffine multivalente Chelatorverbindungen (MCHs) und deren Verwendung zur Struktur- und Funktionsanalyse von Zielmolekülen High-affinity multivalent chelator compounds (MCH) and their use in structural and functional analysis of target molecules
08/17/2011	EP1670772B1 Derivatives of 1,3-diones having a herbicidal activity
08/17/2011	CN102153481A Application of thionyl chloride and alcohol as selective deacylation reagents for N-aryl fatty amide or N-heterocyclic fatty amide
08/17/2011	CN102151262A Compounds for the treatment of metabolic disorders
08/16/2011	US7999116 Explosive complexes
08/11/2011	WO2011094890A1 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
08/11/2011	US20110196111 Light sensitive pdms for complex pattern formation
08/10/2011	CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
08/10/2011	CN102145297A Solid acid catalyst and method for catalytic synthesis of 5-substituted tetrazole by solid acid catalyst
08/09/2011	US7994339 Phthalamide derivative, agricultural or horticultural pesticide, and use of the pesticide
08/04/2011	WO2011031073A3 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
08/04/2011	US20110189210 Method of inhibiting remnant lipoprotein production
08/03/2011	EP2350031A2 Macrocyclic compounds for inhibition of tumor necrosis factor alpha
08/03/2011	CN102140064A Compounds for the treatment of metabolic disorders
08/03/2011	CN101270096B Method for synthesizing diovan
08/02/2011	US7989475 Substituted pyrazoles, compositions containing such compounds and methods of use
08/02/2011	US7988950 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents
07/2011
07/28/2011	US20110184187 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
07/28/2011	US20110184034 Severe sepsis preventive therapeutic agent
07/27/2011	EP2346807A1 Naphthylacetic acids
07/27/2011	CN102137855A Process for preparing certain cinnamide compounds

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 97